- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed Myelodysplastic Syndromes
Total 81170 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); CelgeneRecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome With Excess Blasts | IDH2 Gene Mutation | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 20-30 Percent of Bone Marrow Nucleated CellsUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid LeukemiaCanada, United States
-
National Cancer Institute (NCI)Not yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome
-
Astex Pharmaceuticals, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesSpain, Poland, Bulgaria, Lithuania, Slovakia, Romania
-
Washington University School of MedicineNotable LabsRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Institut Paoli-CalmettesRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesFrance
-
City of Hope Medical CenterNational Cancer Institute (NCI)SuspendedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Bellicum PharmaceuticalsTerminatedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
The Cleveland ClinicCelgeneWithdrawnAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Yale UniversityWithdrawnAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Fox Chase Cancer CenterTerminatedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
medac GmbHCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeGermany, Italy, Poland, France, Finland, Hungary
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Groupe Francophone des MyelodysplasiesUnknownAcute Myeloid Leukemia | Myelodysplastic SyndromesFrance
-
Rigshospitalet, DenmarkVan Andel Research InstituteCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeDenmark
-
Dana-Farber Cancer InstituteCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
National Marrow Donor ProgramCompletedLymphoma | Myelodysplastic Syndromes | LeukemiaUnited States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndrome | 5q Minus SyndromeUnited States
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)China
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRecurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic SyndromesChina
-
Affiliated Hospital to Academy of Military Medical...RecruitingMyelodysplastic Syndromes | Immunotherapy | Dendritic Cell | Hypomethylating AgentsChina
-
Groupe Francophone des MyelodysplasiesActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesFrance, Italy
-
M.D. Anderson Cancer CenterEisai Inc.CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Blood ServicesTerminatedLeukemia | Myelodysplastic SyndromeCanada
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada
-
Merck Sharp & Dohme LLCCompletedMyelodysplastic Syndromes | Anemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndromes (MDS) | Chronic Myelomonocytic Leukemia (CMML) | Low to Intermediate-1 MDSUnited States, France
-
OHSU Knight Cancer InstituteOregon Health and Science University; Oryzon Genomics S.A.Not yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome/Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalRecruitingAcute Myeloid Leukemia, Myelodysplastic Syndrome (MDS)United States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Myeloid NeoplasmUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesChina
-
Richard Stone, MDMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalActive, not recruitingRAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingMDS (Myelodysplastic Syndrome) | Severe Aplastic AnemiaUnited States
-
GCP-Service International West GmbHSaint-Louis Hospital, Paris, France; Groupe Francophone des Myelodysplasies; Australasian... and other collaboratorsRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesAustralia, France, Germany
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); University of Maryland Greenebaum Cancer CenterCompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS
-
M.D. Anderson Cancer CenterCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaCanada, United States
-
Baylor Research InstituteGenzyme, a Sanofi CompanyCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Cooperative Study Group A for HematologyCompletedLeukemia | Myelodysplastic SyndromeKorea, Republic of
-
Singapore General HospitalNational Medical Research Council (NMRC), SingaporeCompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome, High GradeSingapore
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeUnited States
-
University Hospital FreiburgActive, not recruitingMyelodysplastic Syndromes | Juvenile Myelomonocytic LeukemiaGermany
-
University of BirminghamJazz Pharmaceuticals; Adienne SA; IMPACT (funded by NHS Blood & Transplant, Anthony...Active, not recruitingAcute Myeloid Leukaemia | High-risk Myelodysplastic SyndromeUnited Kingdom